Literature DB >> 16102770

Proteome of Aedes aegypti larvae in response to infection by the intracellular parasite Vavraia culicis.

D G Biron1, P Agnew, L Marché, L Renault, C Sidobre, Y Michalakis.   

Abstract

We report on the modification of the Aedes aegypti larval proteome following infection by the microsporidian parasite Vavraia culicis. Mosquito larvae were sampled at 5 and 15 days of age to compare the effects of infection when the parasite was in two different developmental stages. Modifications of the host proteome due to the stress of infection were distinguished from those of a more general nature by treatments involving hypoxia. We found that the major reaction to stress was the suppression of particular protein spots. Older (15 days) larvae reacted more strongly to infection by V. culicis (46% of the total number of spots affected; 17% for 5 days larvae), while the strongest reaction of younger (5 days) larvae was to hypoxia for pH range 5-8 and to combined effects of infection and hypoxia for pH range 3-6. MALDI-TOF results indicate that proteins induced or suppressed by infection are involved directly or indirectly in defense against microorganisms. Finally, our MALDI-TOF results suggest that A. aegypti larvae try to control or clear V. culicis infection and also that V. culicis probably impairs the immune defense of this host via arginases-NOS competition.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16102770     DOI: 10.1016/j.ijpara.2005.05.015

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  17 in total

1.  Do distantly related parasites rely on the same proximate factors to alter the behaviour of their hosts?

Authors:  F Ponton; T Lefevre; C Lebarbenchon; F Thomas; H D Loxdale; L Marché; L Renault; M J Perrot-Minnot; D G Biron
Journal:  Proc Biol Sci       Date:  2006-11-22       Impact factor: 5.349

2.  Changes in the proteomes of the hemocytes and fat bodies of the flesh fly Sarcophaga bullata larvae after infection by Escherichia coli.

Authors:  Alice Masova; Miloslav Sanda; Jiri Jiracek; Irena Selicharova
Journal:  Proteome Sci       Date:  2010-01-13       Impact factor: 2.480

3.  Experimental evolution of specialization by a microsporidian parasite.

Authors:  Mathieu Legros; Jacob C Koella
Journal:  BMC Evol Biol       Date:  2010-05-28       Impact factor: 3.260

4.  Transstadial transmission of larval hemocoelic infection negatively affects development and adult female longevity in the mosquito Anopheles gambiae.

Authors:  Lisa D Brown; Grayson A Thompson; Julián F Hillyer
Journal:  J Invertebr Pathol       Date:  2017-10-27       Impact factor: 2.841

5.  Proteome analysis of Cry4Ba toxin-interacting Aedes aegypti lipid rafts using geLC-MS/MS.

Authors:  Krishnareddy Bayyareddy; Xiang Zhu; Ron Orlando; Michael J Adang
Journal:  J Proteome Res       Date:  2012-11-27       Impact factor: 4.466

6.  Differential proteome analysis of hagfish dental and somatic skeletal muscles.

Authors:  Kuo-Hsun Chiu; Hurng-Wern Huang; Hin-Kiu Mok
Journal:  Mar Biotechnol (NY)       Date:  2007-10-27       Impact factor: 3.619

7.  The microsporidian parasite Vavraia culicis as a potential late life-acting control agent of malaria.

Authors:  Lena M Lorenz; Jacob C Koella
Journal:  Evol Appl       Date:  2011-07-07       Impact factor: 5.183

8.  Maternal environment shapes the life history and susceptibility to malaria of Anopheles gambiae mosquitoes.

Authors:  Lena M Lorenz; Jacob C Koella
Journal:  Malar J       Date:  2011-12-21       Impact factor: 2.979

Review 9.  A review of chemosensation and related behavior in aquatic insects.

Authors:  José G Crespo
Journal:  J Insect Sci       Date:  2011       Impact factor: 1.857

10.  Proteome of Aedes aegypti in response to infection and coinfection with microsporidian parasites.

Authors:  Alison B Duncan; Philip Agnew; Valérie Noel; Edith Demettre; Martial Seveno; Jean-Paul Brizard; Yannis Michalakis
Journal:  Ecol Evol       Date:  2012-04       Impact factor: 2.912

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.